These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 7960139

  • 1. Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum.
    Kaslow DC, Bathurst IC, Lensen T, Ponnudurai T, Barr PJ, Keister DB.
    Infect Immun; 1994 Dec; 62(12):5576-80. PubMed ID: 7960139
    [Abstract] [Full Text] [Related]

  • 2. Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
    Barr PJ, Green KM, Gibson HL, Bathurst IC, Quakyi IA, Kaslow DC.
    J Exp Med; 1991 Nov 01; 174(5):1203-8. PubMed ID: 1940798
    [Abstract] [Full Text] [Related]

  • 3. Plasmodium falciparum: immunogenicity of alum-adsorbed clinical-grade TBV25-28, a yeast-secreted malaria transmission-blocking vaccine candidate.
    Gozar MM, Muratova O, Keister DB, Kensil CR, Price VL, Kaslow DC.
    Exp Parasitol; 2001 Feb 01; 97(2):61-9. PubMed ID: 11281702
    [Abstract] [Full Text] [Related]

  • 4. Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding.
    Kumar R, Angov E, Kumar N.
    Infect Immun; 2014 Apr 01; 82(4):1453-9. PubMed ID: 24421036
    [Abstract] [Full Text] [Related]

  • 5. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T, Komesu A, Otsuki H, Sattabongkot J, Udomsangpetch R, Matsumoto Y, Tsuji N, Wu Y, Torii M, Tsuboi T.
    Infect Immun; 2005 Nov 01; 73(11):7375-80. PubMed ID: 16239536
    [Abstract] [Full Text] [Related]

  • 6. Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.
    Coban C, Ishii KJ, Stowers AW, Keister DB, Klinman DM, Kumar N.
    Infect Immun; 2004 Jan 01; 72(1):584-8. PubMed ID: 14688140
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.
    Patra KP, Li F, Carter D, Gregory JA, Baga S, Reed SG, Mayfield SP, Vinetz JM.
    Infect Immun; 2015 May 01; 83(5):1799-808. PubMed ID: 25690099
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.
    Gozar MM, Price VL, Kaslow DC.
    Infect Immun; 1998 Jan 01; 66(1):59-64. PubMed ID: 9423839
    [Abstract] [Full Text] [Related]

  • 13. Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.
    Lee SM, Wu CK, Plieskatt J, McAdams DH, Miura K, Ockenhouse C, King CR.
    Malar J; 2016 Aug 11; 15(1):405. PubMed ID: 27515826
    [Abstract] [Full Text] [Related]

  • 14. Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.
    Roeffen W, Theisen M, van de Vegte-Bolmer M, van Gemert G, Arens T, Andersen G, Christiansen M, Sevargave L, Singh SK, Kaviraj S, Sauerwein R.
    Malar J; 2015 Nov 09; 14():443. PubMed ID: 26552428
    [Abstract] [Full Text] [Related]

  • 15. Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.
    Kapoor N, Vanjak I, Rozzelle J, Berges A, Chan W, Yin G, Tran C, Sato AK, Steiner AR, Pham TP, Birkett AJ, Long CA, Fairman J, Miura K.
    Biochemistry; 2018 Feb 06; 57(5):516-519. PubMed ID: 29323879
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A viral vectored prime-boost immunization regime targeting the malaria Pfs25 antigen induces transmission-blocking activity.
    Goodman AL, Blagborough AM, Biswas S, Wu Y, Hill AV, Sinden RE, Draper SJ.
    PLoS One; 2011 Feb 06; 6(12):e29428. PubMed ID: 22216279
    [Abstract] [Full Text] [Related]

  • 19. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
    Agrawal A, Bisharyan Y, Papoyan A, Bednenko J, Cardarelli J, Yao M, Clark T, Berkmen M, Ke N, Colussi P.
    Protein Expr Purif; 2019 Jan 06; 153():7-17. PubMed ID: 30081196
    [Abstract] [Full Text] [Related]

  • 20. Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study.
    Sharma B.
    In Silico Biol; 2008 Jan 06; 8(3-4):193-206. PubMed ID: 19032156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.